Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
Medicines Australia CEO Elizabeth de Somer talks about how the CEP program provides the information needed by medical representatives, that talk to health care professionals, talk with accuracy, balance and in an evidence based manner about their products.
Australian Health Journal spoke with recent CEP graduates Samantha Wicks, Christopher Lems and Megan-Anne Jefferys on their experiences in the program and how it positively impacted their confidence and knowledge of the industry.
The CEP is currently offered online through the University of Tasmania’s Unit for Medication Outcomes Research and Education (UMORE), which is housed in the University’s Pharmacy Division.
You Might also like
-
Dentist creates app to democratise oral health care
In this People In Health Care segment, Dr Gadiyar spoke to Australian Health Journal on how she hopes the app will help increase the number of people seeking dental treatment from the current 47% level in Australia. To date, 120,000 users have downloaded the app with more than 50 dental practices signed up with Smilo.ai to receive individual enquiries or seek dental treatment.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
AHW Exhibitor: Gentec Australia
Gentec Australia, an Australian supplier of tapware and designer of wash basins to the healthcare industry exhibited at last week’s Australian Healthcare Week 2019. Their patented basin design reduces the risk of infection through splashing from water through an offset waste, as well as other infection control features. Know My Group reporter Anne Dao spoke with General Manager for Sales Graeme Bunt and State Manager (VIC) Vanessa Beever.
In an upcoming segment Australian Health Journal will cover the technologies deployed and steps taken by hospitals and clinics in infection control.
Post Views:
1,315